EDITORIAL
Accepted on 13 Aug 2025
Editorial: Immune Tolerance Dual Role-Advancements in Cancer and Autoimmune Diseases
doi 10.3389/fimmu.2025.1676002
- 143 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune Tolerance Dual Role: Advancements in Cancer and Autoimmune Diseases
Immune Tolerance Dual Role: Advancements in Cancer and Autoimmune Diseases
5,479
Total downloads
22k
Total views and downloads
Articles
CASE REPORT
Published on 06 Aug 2025
Tislelizumab-induced hemophagocytic lymphohistiocytosis in a patient with microsatellite instability-high colon cancer and coexisting systemic lupus erythematosus: a case report and literature review
doi 10.3389/fonc.2025.1585133
- 286 views
REVIEW
Published on 02 May 2025
The dual roles of human PYHIN family proteins in cancer: mechanisms and therapeutic implications
doi 10.3389/fimmu.2025.1576674
- 1,200 views
CASE REPORT
Published on 17 Mar 2025
Case Report: Pembrolizumab in a patient with preexisting paraneoplastic dermatomyositis and sarcomatoid urothelial carcinoma. Searching for balance
doi 10.3389/fimmu.2025.1558964
- 1,527 views
- 1 citation
REVIEW
Published on 14 Feb 2025
Big lessons from the little Akkermansia muciniphila in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1524563
- 2,894 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 Jan 2025
Mixed radiation with different doses induces CCL17 to recruit CD8+T cell to exert anti-tumor effects in non-small cell lung cancer
doi 10.3389/fimmu.2024.1508007
- 1,535 views
- 2 citations
ORIGINAL RESEARCH
Published on 29 Nov 2024
A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study
doi 10.3389/fimmu.2024.1481326
- 1,301 views
ORIGINAL RESEARCH
Published on 13 Nov 2024
Protective effects of YCHD on the autoimmune hepatitis mice model induced by Ad-CYP2D6 through modulating the Th1/Treg ratio and intestinal flora
doi 10.3389/fimmu.2024.1488125
- 2,656 views
ORIGINAL RESEARCH
Published on 30 Oct 2024
Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma
doi 10.3389/fimmu.2024.1462064
- 1,867 views
ORIGINAL RESEARCH
Published on 19 Sep 2024
CCL4 as a potential serum factor in differential diagnosis of central nervous system inflammatory diseases and gliomas
doi 10.3389/fimmu.2024.1461450
- 1,545 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore